We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPEV icon
1426
XPeng
XPEV
$12.2B
$530K ﹤0.01%
12,381
-18,163
-59% -$667K
APPS icon
1427
Digital Turbine
APPS
$1.03B
$529K ﹤0.01%
+9,352
New +$384K
VRNS icon
1428
Varonis Systems
VRNS
$5.27B
$527K ﹤0.01%
9,669
-73,314
-88% -$3.18M
NCNO icon
1429
nCino
NCNO
$2.05B
$526K ﹤0.01%
7,265
+3,017
+71% +$233K
FMTX
1430
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$526K ﹤0.01%
+15,089
New +$657K
CURO
1431
DELISTED
CURO Group Holdings Corp.
CURO
$524K ﹤0.01%
+36,598
New +$337K
RRGB icon
1432
Red Robin
RRGB
$137M
$521K ﹤0.01%
27,113
-99,326
-79% -$1.67M
MOR
1433
DELISTED
MorphoSys AG American Depositary Shares
MOR
$521K ﹤0.01%
18,383
-43,764
-70% -$1.2M
AIA icon
1434
iShares Asia 50 ETF
AIA
$4.4B
$519K ﹤0.01%
+5,950
New +$475K
DCOM icon
1435
Dime Commercial Bancshares
DCOM
$1.81B
$519K ﹤0.01%
21,473
-14,462
-40% -$313K
MOFG
1436
DELISTED
MidWestOne Financial Group
MOFG
$518K ﹤0.01%
21,131
-868
-4% -$19.8K
PDCO
1437
DELISTED
Patterson Companies, Inc.
PDCO
$518K ﹤0.01%
+17,499
New +$496K
EQNR icon
1438
Equinor
EQNR
$90.9B
$516K ﹤0.01%
31,430
-188,066
-86% -$2.84M
LITE icon
1439
Lumentum
LITE
$50.2B
$516K ﹤0.01%
+5,438
New +$469K
CVCO icon
1440
Cavco Industries
CVCO
$4.55B
$515K ﹤0.01%
2,933
-12,245
-81% -$2.27M
CMD
1441
DELISTED
Cantel Medical Corporation
CMD
$515K ﹤0.01%
6,540
-37,038
-85% -$2.17M
TTWO icon
1442
Take-Two Interactive
TTWO
$45.9B
$514K ﹤0.01%
2,475
-112,107
-98% -$19.6M
NVCR icon
1443
NovoCure
NVCR
$1.92B
$511K ﹤0.01%
+2,951
New +$404K
TMPOW
1444
CALL
DELISTED
Tempo Automation Holdings, Inc. Warrant
TMPOW
$511K ﹤0.01%
+49,999
New +$43.4K
ESI icon
1445
Element Solutions
ESI
$8.81B
$509K ﹤0.01%
28,717
-172,374
-86% -$2.38M
TRUE
1446
DELISTED
TrueCar
TRUE
$505K ﹤0.01%
120,186
-214,895
-64% -$958K
QTNT
1447
DELISTED
Quotient Limited Ordinary Shares
QTNT
$505K ﹤0.01%
2,427
-1,432
-37% -$333K
SAIC icon
1448
Saic
SAIC
$5.14B
$504K ﹤0.01%
+5,321
New +$468K
SYRS
1449
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$504K ﹤0.01%
+4,642
New +$424K
EVLO
1450
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$500K ﹤0.01%
+2,069
New +$256K

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.